Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 51.3M | 35.3M | 26.4M | 19.4M |
| Selling general and admin | 12.3M | 12.0M | 13.0M | 11.7M |
| Other operating expenses | — | — | — | — |
| Operating income | -63.6M | -47.3M | -39.4M | -31.2M |
| Non operating interest income | ||||
| Income | 7.7M | 8.4M | 9.2M | 9.8M |
| Expense | — | — | — | — |
| Other income expense | 3.4K | — | 852 | 93.0K |
| Pretax income | -55.9M | -38.9M | -30.2M | -21.3M |
| Tax provision | — | — | — | — |
| Net income | -55.9M | -38.9M | -30.2M | -21.3M |
| Basic EPS | -0.6 | -0.4 | -0.3 | -0.2 |
| Diluted EPS | -0.6 | -0.4 | -0.3 | -0.2 |
| Basic average shares | 95.7M | 95.6M | 95.0M | 94.6M |
| Diluted average shares | 95.7M | 95.6M | 95.0M | 94.6M |
| EBITDA | -63.5M | -47.2M | -39.3M | -31.2M |
| Net income from continuing op. | -55.9M | -38.9M | -30.2M | -21.3M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |